Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
18.99
+0.06 (0.32%)
Aug 14, 2025, 2:09 PM - Market open

Korro Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-91.36-83.58-81.17-58.03-21.96
Depreciation & Amortization
4.573.573.632.511.6
Loss (Gain) From Sale of Assets
0.440.360.07-0.01
Loss (Gain) From Sale of Investments
-2.03-1.78-0.08-0.150.02
Stock-Based Compensation
6.394.462.381.140.81
Other Operating Activities
1.333.313.611.51-13.47
Change in Accounts Receivable
-1.09-1.7---
Change in Accounts Payable
0.36-1.343.11.760.06
Change in Unearned Revenue
8.439.43---0.69
Change in Other Net Operating Assets
5.697.21.18-2.391.53
Operating Cash Flow
-67.27-60.07-67.28-53.65-32.09
Capital Expenditures
-6.59-17.9-7.84-5.21-4.45
Sale of Property, Plant & Equipment
----0.01
Investment in Securities
12.73-105.451916.27-35.07
Investing Cash Flow
6.14-123.3511.1611.06-39.5
Issuance of Common Stock
1.8469.36154.550.060.03
Other Financing Activities
---12.25-0.04-0.03
Financing Cash Flow
1.8469.36187.760.02115.95
Foreign Exchange Rate Adjustments
-0.01-0---
Net Cash Flow
-59.31-114.07131.64-42.5744.35
Free Cash Flow
-73.86-77.98-75.12-58.86-36.54
Free Cash Flow Margin
-1175.91%-3433.55%---
Free Cash Flow Per Share
-7.89-8.74-49.12-230.65-8.22
Cash Income Tax Paid
0.10.140.030.01-
Levered Free Cash Flow
-54.42-69.99-47.69-38.2-
Unlevered Free Cash Flow
-54.42-69.99-47.69-38.2-
Change in Working Capital
13.3913.594.28-0.630.9
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q